307 related articles for article (PubMed ID: 12582447)
41. Tiotropium versus salmeterol in COPD.
Schembri S
N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714655
[No Abstract] [Full Text] [Related]
42. The role of anticholinergics in chronic obstructive pulmonary disease.
Barnes PJ
Am J Med; 2004 Dec; 117 Suppl 12A():24S-32S. PubMed ID: 15693640
[TBL] [Abstract][Full Text] [Related]
43. The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
Beeh KM; Derom E; Echave-Sustaeta J; Grönke L; Hamilton A; Zhai D; Bjermer L
Int J Chron Obstruct Pulmon Dis; 2016; 11():193-205. PubMed ID: 26893551
[TBL] [Abstract][Full Text] [Related]
44. Tiotropium versus salmeterol in COPD.
Restrick L; Stern M; Baxter N
N Engl J Med; 2011 Jun; 364(26):2552; author reply 2553-4. PubMed ID: 21714657
[No Abstract] [Full Text] [Related]
45. Tiotropium: a new therapeutic option in asthma.
Novelli F; Costa F; Latorre M; Malagrinò L; Celi A; Vagaggini B; Paggiaro P
Monaldi Arch Chest Dis; 2013; 79(3-4):109-15. PubMed ID: 24761528
[TBL] [Abstract][Full Text] [Related]
46. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.
Niewoehner DE; Rice K; Cote C; Paulson D; Cooper JA; Korducki L; Cassino C; Kesten S
Ann Intern Med; 2005 Sep; 143(5):317-26. PubMed ID: 16144890
[TBL] [Abstract][Full Text] [Related]
47. Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
Dalal AA; Roberts MH; Petersen HV; Blanchette CM; Mapel DW
Int J Chron Obstruct Pulmon Dis; 2010 Dec; 6():13-22. PubMed ID: 21311689
[TBL] [Abstract][Full Text] [Related]
48. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease.
Joos GF; Brusselle G; Derom E; Pauwels R
Int J Clin Pract; 2003 Dec; 57(10):906-9. PubMed ID: 14712894
[TBL] [Abstract][Full Text] [Related]
49. Inhaled tiotropium for stable chronic obstructive pulmonary disease.
Barr RG; Bourbeau J; Camargo CA; Ram FS
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002876. PubMed ID: 15846642
[TBL] [Abstract][Full Text] [Related]
50. Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations.
Beeh KM; Hederer B; Glaab T; Müller A; Rutten-van Moelken M; Kesten S; Vogelmeier C
Int J Chron Obstruct Pulmon Dis; 2009; 4():119-25. PubMed ID: 19436693
[TBL] [Abstract][Full Text] [Related]
51. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
Casaburi R; Mahler DA; Jones PW; Wanner A; San PG; ZuWallack RL; Menjoge SS; Serby CW; Witek T
Eur Respir J; 2002 Feb; 19(2):217-24. PubMed ID: 11866001
[TBL] [Abstract][Full Text] [Related]
52. In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers.
Horhota ST; van Noord JA; Verkleij CB; Bour LJ; Sharma A; Trunk M; Cornelissen PJ
AAPS J; 2015 Jul; 17(4):871-80. PubMed ID: 25794622
[TBL] [Abstract][Full Text] [Related]
53. Tiotropium versus salmeterol in COPD.
Lloret-Linares C; Bergmann JF
N Engl J Med; 2011 Jun; 364(26):2552-3; author reply 2553-4. PubMed ID: 21714656
[No Abstract] [Full Text] [Related]
54. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
Salpeter SR
Drugs; 2009 Oct; 69(15):2025-33. PubMed ID: 19791824
[TBL] [Abstract][Full Text] [Related]
55. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.
Vincken W; van Noord JA; Greefhorst AP; Bantje TA; Kesten S; Korducki L; Cornelissen PJ;
Eur Respir J; 2002 Feb; 19(2):209-16. PubMed ID: 11871363
[TBL] [Abstract][Full Text] [Related]
56. Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.
Panning CA; DeBisschop M
Pharmacotherapy; 2003 Feb; 23(2):183-9. PubMed ID: 12587807
[TBL] [Abstract][Full Text] [Related]
57. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
Welsh EJ; Cates CJ; Poole P
Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
[TBL] [Abstract][Full Text] [Related]
58. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
59. Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
Magnussen H; Disse B; Rodriguez-Roisin R; Kirsten A; Watz H; Tetzlaff K; Towse L; Finnigan H; Dahl R; Decramer M; Chanez P; Wouters EF; Calverley PM;
N Engl J Med; 2014 Oct; 371(14):1285-94. PubMed ID: 25196117
[TBL] [Abstract][Full Text] [Related]
60. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
